Laboratory testing for heritable thrombophilia: Impact on clinical management of thrombotic disease

被引：43
作者：
Greaves, M
Baglin, T
机构：
[1] Univ Aberdeen, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
[2] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2000年 / 109卷 / 04期
关键词：
thrombosis; thrombophilia; genetic screening;
D O I：
10.1046/j.1365-2141.2000.02185.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：699 / 703
页数：5
相关论文
共 26 条
[21]  
TAIT RC, 1993, THROMB HAEMOSTASIS, V70, P281
[22]  
vanBoven HH, 1996, THROMB HAEMOSTASIS, V75, P417
[23]   Recurrence of venous thromboembolism in patients with familial thrombophilia [J].
vandenBelt, AGM ;
Sanson, BJ ;
Simioni, P ;
Prandoni, P ;
Buller, HR ;
Girolami, A ;
Prins, MH .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (19) :2227-2232
[24]   Factor V Leiden: Should we screen oral contraceptive users and pregnant women? [J].
Vandenbroucke, JP ;
vanderMeer, FJM ;
Helmerhorst, FM ;
Rosendaal, FR .
BRITISH MEDICAL JOURNAL, 1996, 313 (7065) :1127-1130
[25]   INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION [J].
VANDENBROUCKE, JP ;
KOSTER, T ;
BRIET, E ;
REITSMA, PH ;
BERTINA, RM ;
ROSENDAAL, FR .
LANCET, 1994, 344 (8935) :1453-1457
[26]   RESISTANCE TO ACTIVATED PROTEIN-C AS AN ADDITIONAL GENETIC RISK FACTOR IN HEREDITARY-DEFICIENCY OF PROTEIN-S [J].
ZOLLER, B ;
BERNTSDOTTER, A ;
DE FRUTOS, PG ;
DAHLBACK, B .
BLOOD, 1995, 85 (12) :3518-3523
123